$Pacira BioSciences (PCRX.US)$ On October 12, Pacira BioScie...

$Pacira BioSciences(PCRX.US)$ $Flexion Therapeutics Inc(FLXN.US)$ On October 12, Pacira BioSciences announced that it has entered into a definitive agreement to acquire Flexion Therapeutics For $8.50 per share, or approximately $430 million, in cash to enhance its non-opioid pain portfolio. The deal also includes contingent valuable rights worth up to $8.00 per share, which are tied to Zilretta sales targets and FDA approvals for FX201 and FX301.